Stock listing
4OR Stock Price, News, Filings & Events — Vivosim Labs, Inc.
Selected listing: 4OR · FWB · EUR · DE
This page tracks Vivosim Labs, Inc.'s 4OR:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4OR:FWB. 4OR:FWB is the stock-level entry point for investors researching Vivosim Labs, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vivosim Labs, Inc. (Ticker: VIVS) is a public company based in the United States with a market capitalization of approximately $1.46 million. The company operates in the technology sector, focusing on innovative solutions. Vivosim Labs aims to advance its offerings and expand its presence in the market.
- Ticker
- 4OR:FWB
- Asset type
- Stock
- Market cap
- $4.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- FWB
- Currency
- EUR
Vivosim Labs, Inc. 4OR:FWB stock context
This page tracks Vivosim Labs, Inc.'s 4OR:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 4OR:FWB. 4OR:FWB is the stock-level entry point for investors researching Vivosim Labs, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Vivosim Labs, Inc. (Ticker: VIVS) is a public company based in the United States with a market capitalization of approximately $1.46 million. The company operates in the technology sector, focusing on innovative solutions. Vivosim Labs aims to advance its offerings and expand its presence in the market.
Latest news from Vivosim Labs, Inc.
VivoSim Labs to Add Rat Liver Model to NAMkind Platform
September 1, 2026
VivoSim Enters China with First Commercial Sales of NAMkind™ Toxicology Screening and Efficacy Testing Services
July 21, 2026
VivoSim Announces Pricing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules with a Single Healthcare Focused Inst...
July 16, 2026
VivoSim Receives $5M Milestone Payment from Eli Lilly; Provides Guidance That It Expects Revenue Growth of 500%+ in FY2027
July 15, 2026
VivoSim Presents Data Showing Superiority to Competition in NAM Liver Tox Prediction at European Toxicology Meeting
June 29, 2026
Research Vivosim Labs, Inc.
Vivosim Labs, Inc. investor report
Review AI stock analysis and investor report context for 4OR:FWB.
Vivosim Labs, Inc. company profile
View the public company page for Vivosim Labs, Inc. on 6ix.
Vivosim Labs, Inc. news
Read company news and market updates connected to Vivosim Labs, Inc..
Vivosim Labs, Inc. investor events
Find investor webinars, events, and replay context for Vivosim Labs, Inc..
Alternate listings
VIVS:NASDAQ
US · USD
Alternate listing for Vivosim Labs, Inc.; the primary context on this page is 4OR:FWB.
4OR:MUN
DE · EUR
Alternate listing for Vivosim Labs, Inc.; the primary context on this page is 4OR:FWB.
0R02:LSE
GB · USD
Alternate listing for Vivosim Labs, Inc.; the primary context on this page is 4OR:FWB.
4OR:GETTEX
DE · EUR
Alternate listing for Vivosim Labs, Inc.; the primary context on this page is 4OR:FWB.
VIVS:BOATS
US · USD
Alternate listing for Vivosim Labs, Inc.; the primary context on this page is 4OR:FWB.
A41083:LSX
DE · EUR
Alternate listing for Vivosim Labs, Inc.; the primary context on this page is 4OR:FWB.
A41083:LS
DE · EUR
Alternate listing for Vivosim Labs, Inc.; the primary context on this page is 4OR:FWB.
4OR:SWB
DE · EUR
Alternate listing for Vivosim Labs, Inc.; the primary context on this page is 4OR:FWB.